Formulation |
Concentration of test solution (%) |
2 |
1 |
0.5 |
Day After treatment, DAT |
1 |
2 |
3 |
1 |
2 |
3 |
1 |
2 |
3 |
A |
100.0g |
100.0g |
100.0g |
100. 0g |
100.0g |
100.0g |
100.0g |
100.0g |
100.0g |
B |
100.0g |
100.0g |
100.0g |
100.0g |
100.0g |
100.0g |
100.0g |
100.0g |
100. 0g |
C |
74.46d |
78.33d |
78.33d |
52.34c |
52.34c |
52.34c |
39.52b |
39.52b |
39.52b |
D |
81.66e |
81.66e |
81.66e |
55.37c |
55.37c |
55.37c |
41.33b |
41.33b |
41.33b |
E |
85.00e |
85.00 e |
88.74e |
58.82c |
75.42d |
75.42d |
44.48b |
44.48b |
53.20c |
F |
100.00g |
100.00g |
100.00g |
91.44f |
91.44f |
100.00g |
82.32e |
82.32e |
82.32e |
Control |
0.0a |
0.0a |
0.0a |
0.0a |
0.0a |
0.0a |
0.0a |
0.0a |
0.0a |
|